Incidental Mutation 'R0736:Mapk9'
ID 67301
Institutional Source Beutler Lab
Gene Symbol Mapk9
Ensembl Gene ENSMUSG00000020366
Gene Name mitogen-activated protein kinase 9
Synonyms c-Jun N-terminal kinase, Prkm9, JNK2, JNK/SAPK alpha
MMRRC Submission 038917-MU
Accession Numbers
Essential gene? Possibly non essential (E-score: 0.342) question?
Stock # R0736 (G1)
Quality Score 225
Status Not validated
Chromosome 11
Chromosomal Location 49737578-49777248 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) G to A at 49774081 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Aspartic acid to Asparagine at position 413 (D413N)
Ref Sequence ENSEMBL: ENSMUSP00000136977 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000020634] [ENSMUST00000043321] [ENSMUST00000102778] [ENSMUST00000109178] [ENSMUST00000109179] [ENSMUST00000164643] [ENSMUST00000178543]
AlphaFold Q9WTU6
Predicted Effect possibly damaging
Transcript: ENSMUST00000020634
AA Change: D413N

PolyPhen 2 Score 0.577 (Sensitivity: 0.88; Specificity: 0.91)
SMART Domains Protein: ENSMUSP00000020634
Gene: ENSMUSG00000020366
AA Change: D413N

DomainStartEndE-ValueType
S_TKc 26 321 4.01e-87 SMART
low complexity region 387 399 N/A INTRINSIC
low complexity region 403 416 N/A INTRINSIC
Predicted Effect possibly damaging
Transcript: ENSMUST00000043321
AA Change: D413N

PolyPhen 2 Score 0.577 (Sensitivity: 0.88; Specificity: 0.91)
SMART Domains Protein: ENSMUSP00000042744
Gene: ENSMUSG00000020366
AA Change: D413N

DomainStartEndE-ValueType
S_TKc 26 321 7.6e-88 SMART
low complexity region 387 399 N/A INTRINSIC
low complexity region 403 416 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000102778
SMART Domains Protein: ENSMUSP00000099839
Gene: ENSMUSG00000020366

DomainStartEndE-ValueType
S_TKc 26 321 7.6e-88 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000109178
SMART Domains Protein: ENSMUSP00000104807
Gene: ENSMUSG00000020366

DomainStartEndE-ValueType
S_TKc 26 321 4.01e-87 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000109179
SMART Domains Protein: ENSMUSP00000104808
Gene: ENSMUSG00000020366

DomainStartEndE-ValueType
S_TKc 26 321 7.6e-88 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000164643
SMART Domains Protein: ENSMUSP00000132864
Gene: ENSMUSG00000020366

DomainStartEndE-ValueType
S_TKc 26 321 4.01e-87 SMART
Predicted Effect possibly damaging
Transcript: ENSMUST00000178543
AA Change: D413N

PolyPhen 2 Score 0.577 (Sensitivity: 0.88; Specificity: 0.91)
SMART Domains Protein: ENSMUSP00000136977
Gene: ENSMUSG00000020366
AA Change: D413N

DomainStartEndE-ValueType
S_TKc 26 321 7.6e-88 SMART
low complexity region 387 399 N/A INTRINSIC
low complexity region 403 416 N/A INTRINSIC
Coding Region Coverage
  • 1x: 99.6%
  • 3x: 99.0%
  • 10x: 97.6%
  • 20x: 95.3%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase targets specific transcription factors, and thus mediates immediate-early gene expression in response to various cell stimuli. It is most closely related to MAPK8, both of which are involved in UV radiation induced apoptosis, thought to be related to the cytochrome c-mediated cell death pathway. This gene and MAPK8 are also known as c-Jun N-terminal kinases. This kinase blocks the ubiquitination of tumor suppressor p53, and thus it increases the stability of p53 in nonstressed cells. Studies of this gene's mouse counterpart suggest a key role in T-cell differentiation. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Sep 2008]
PHENOTYPE: Homozygotes for a null allele show resistance to TNF-induced liver injury, impaired TH1 cell differentiation, and enhanced epidermal differentiation and proliferation. Homozygotes for a reporter allele show impaired T-cell activation and apoptosis, resistance to I-R cardiac injury, and reduced LTP. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 29 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Amn1 G A 6: 149,084,970 (GRCm39) H37Y possibly damaging Het
Cacna2d3 A T 14: 28,780,585 (GRCm39) H644Q probably benign Het
Calb1 G A 4: 15,898,917 (GRCm39) V138M probably benign Het
Cep55 C A 19: 38,061,765 (GRCm39) T402N probably benign Het
Chrnb3 G A 8: 27,875,078 (GRCm39) A26T probably benign Het
Col6a3 C T 1: 90,731,811 (GRCm39) V1481I possibly damaging Het
Dmxl2 C T 9: 54,286,101 (GRCm39) V2695I probably damaging Het
Elapor2 A T 5: 9,491,745 (GRCm39) S702C probably damaging Het
Heatr5a A C 12: 51,943,344 (GRCm39) probably null Het
Kmt2c C T 5: 25,500,432 (GRCm39) M461I probably benign Het
Morc4 G T X: 138,755,700 (GRCm39) Q239K probably benign Het
Myt1l T A 12: 29,877,813 (GRCm39) V488D unknown Het
Neb A T 2: 52,082,024 (GRCm39) Y24N probably damaging Het
Neo1 G A 9: 58,824,364 (GRCm39) P688L possibly damaging Het
Nlrp9b A T 7: 19,783,375 (GRCm39) D409V probably damaging Het
Pcare A G 17: 72,051,659 (GRCm39) V1231A probably benign Het
Pde7a T C 3: 19,285,207 (GRCm39) N327D probably damaging Het
Pdzd8 C A 19: 59,333,365 (GRCm39) V219L probably damaging Het
Pgc T A 17: 48,039,705 (GRCm39) M33K probably damaging Het
Pik3ap1 T A 19: 41,320,758 (GRCm39) T154S possibly damaging Het
Polm G C 11: 5,785,495 (GRCm39) S188C possibly damaging Het
Slfn1 A T 11: 83,011,907 (GRCm39) T8S probably benign Het
St8sia6 C T 2: 13,673,696 (GRCm39) V179M probably benign Het
Tns3 A T 11: 8,469,474 (GRCm39) F274I possibly damaging Het
Tspan5 T C 3: 138,574,159 (GRCm39) probably null Het
Utp14b A G 1: 78,642,989 (GRCm39) K296E probably damaging Het
Zbtb14 A G 17: 69,694,797 (GRCm39) E165G possibly damaging Het
Zbtb17 C A 4: 141,189,097 (GRCm39) H6N probably damaging Het
Zw10 C T 9: 48,975,432 (GRCm39) H286Y probably benign Het
Other mutations in Mapk9
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL03085:Mapk9 APN 11 49,757,865 (GRCm39) missense probably damaging 1.00
IGL03399:Mapk9 APN 11 49,774,126 (GRCm39) utr 3 prime probably benign
Infirm UTSW 11 49,754,383 (GRCm39) missense probably damaging 1.00
R0003:Mapk9 UTSW 11 49,757,866 (GRCm39) missense possibly damaging 0.52
R0610:Mapk9 UTSW 11 49,754,400 (GRCm39) missense probably benign 0.00
R0676:Mapk9 UTSW 11 49,773,983 (GRCm39) makesense probably null
R0681:Mapk9 UTSW 11 49,760,072 (GRCm39) missense probably damaging 1.00
R1186:Mapk9 UTSW 11 49,769,096 (GRCm39) missense probably damaging 0.99
R1964:Mapk9 UTSW 11 49,745,160 (GRCm39) missense probably null 1.00
R2424:Mapk9 UTSW 11 49,754,499 (GRCm39) missense probably damaging 1.00
R4876:Mapk9 UTSW 11 49,745,152 (GRCm39) missense probably damaging 0.97
R6191:Mapk9 UTSW 11 49,754,383 (GRCm39) missense probably damaging 1.00
R7059:Mapk9 UTSW 11 49,757,874 (GRCm39) splice site probably null
R7484:Mapk9 UTSW 11 49,763,663 (GRCm39) missense probably damaging 0.97
R7951:Mapk9 UTSW 11 49,754,422 (GRCm39) missense probably damaging 1.00
R8834:Mapk9 UTSW 11 49,774,010 (GRCm39) missense probably damaging 1.00
R9104:Mapk9 UTSW 11 49,760,000 (GRCm39) missense probably damaging 1.00
R9158:Mapk9 UTSW 11 49,745,095 (GRCm39) missense probably benign 0.02
R9176:Mapk9 UTSW 11 49,763,565 (GRCm39) nonsense probably null
R9573:Mapk9 UTSW 11 49,769,239 (GRCm39) missense probably damaging 0.99
RF010:Mapk9 UTSW 11 49,745,083 (GRCm39) start gained probably benign
Predicted Primers PCR Primer
(F):5'- ACTTGGATGCTACGCAGACCTAAAC -3'
(R):5'- AATCCTACTGGAACTGAGCAGGGC -3'

Sequencing Primer
(F):5'- ACATGGTCTTATGTGACCACAGG -3'
(R):5'- GCAAGGCATCGTGTTTCTTAC -3'
Posted On 2013-09-03